High Content Screening: TrendBio partner with Yokogawa Life Sciences
17 June 2019
We are proud to announce a newly formed partnership with Yokogawa Life Sciences, Japan.
As of 2019, TrendBio will distribute and support Yokogawa’s High Content Analysis portfolio in Oceania, bringing to the region new generation developments in the area of automated confocal microscopy. Built upon Yokogawa’s superb dual spinning disk technology, this partnership strengthens TrendBio’s existing cell biology portfolio by enabling high quality fluorescence, label free and 3D imaging application capabilities.
We are excited about upcoming future developments in this area which will see advancements in machine learning analysis tools as well as integration of multi-omics modalities.
Explore Yokogawa’s High Content Analysis portfolio in the Learn More section below.